
无数据
无数据
无数据
| CAS Number | 89-25-8 |
| Catalog Number | AG0087X2(AGN-PC-03EAVU) |
| Chemical Name | Edaravone |
| EC Number | 201-891-0 |
| IUPAC Name | 5-methyl-2-phenyl-4H-pyrazol-3-one |
| InChI | InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3 |
| InChI Key | QELUYTUMUWHWMC-UHFFFAOYSA-N |
| MDL Number | MFCD00003138 |
| Molecular Formula | C10H10N2O |
| Molecular Weight | 174.1992 |
| SMILES | O=C1CC(C)=NN1C2=CC=CC=C2 |
| Synonyms | 1 Phenyl 3 methyl 5 pyrazolone,
1-phenyl-3-methyl-5-pyrazolone,
3 Methyl 1 phenyl 2 pyrazolin 5 one,
3-methyl-1-phenyl-2-pyrazolin-5-one,
edarabone,
edaravone,
MCI 186,
MCI-186,
MCI186,
norantipyrine,
norphenazone,
phenylmethylpyrazolone,
Radicava,
edaravone,
89-25-8,
3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE,
Radicut,
1-Phenyl-3-methyl-5-pyrazolone,
Norphenazone,
Developer Z,
MCI-186,
Methylphenylpyrazolone,
Norantipyrine,
C.I. Developer 1,
Phenylmethylpyrazolone,
Phenyl methyl pyrazolone,
Radicava,
1-Phenyl-3-methyl-5-oxo-2-pyrazoline,
1-Phenyl-3-methylpyrazolone,
CI Developer 1,
3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-,
3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one,
1-Phenyl-3-methylpyrazolone-5,
2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one,
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one,
3-Methyl-1-phenylpyrazol-5-one,
3-Methyl-1-phenyl-2-pyrazoline-5-one,
NCI-C03952,
2-Pyrazolin-5-one, 3-methyl-1-phenyl-,
5-Pyrazolone, 3-methyl-1-phenyl-,
5-methyl-2-phenyl-4H-pyrazol-3-one,
NSC 12,
Edaravone (MCI-186),
1-Fenyl-3-methyl-2-pyrazolin-5-on,
MFCD00003138,
CCRIS 512,
CHEBI:31530,
HSDB 4102,
1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech],
EINECS 201-891-0,
3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one,
BRN 0609575,
AI3-03557,
MLS000069602,
QELUYTUMUWHWMC-UHFFFAOYSA-N,
NSC-2629,
NSC-26139,
3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE (MCI-186),
NCGC00164015-01,
SMR000059020,
edaravone(jan),
DSSTox_CID_1130,
DSSTox_RID_75961,
DSSTox_GSID_21130,
Monopyrazolone,
WLN: T5NMV DHJ BR& E1,
1-Phenyl-3-methyl-2-pyrazolin-5-on,
CAS-89-25-8,
Radicut (TN),
3-Methyl-1-phenyl-2-pyrazolin-5-one, 99%,
3H-Pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-,
SR-01000000135,
Radicava (TN),
(MCI-186),
IN1263,
Radicut;MCI-186,
CDS1_000986,
PubChem13301,
Spectrum_000267,
Tocris-0786,
Edaravone [USAN:INN],
AC1Q2PHG,
AC1Q6EYP,
Maybridge1_005738,
Opera_ID_1057,
Spectrum2_001574,
Spectrum3_000971,
Spectrum4_001091,
Spectrum5_001217,
M0687,
Edaravone (JP17/INN),
EC 201-891-0,
AC1L1H8H,
SCHEMBL4704,
BSPBio_001235,
BSPBio_002601,
KBioGR_000575,
KBioGR_001502,
KBioSS_000575,
KBioSS_000747,
AE-641/00371017,
KSC448M1D,
MLS001146878,
MLS002415675,
MLS006011753,
DivK1c_001018,
DivK1c_002026,
SPECTRUM1503635,
SPBio_001508,
CHEMBL290916,
DTXSID9021130,
BCBcMAP01_000127,
CTK3E8611,
HMS503K17,
HMS557M18,
KBio1_001018,
KBio2_000575,
KBio2_000747,
KBio2_003143,
KBio2_003315,
KBio2_005711,
KBio2_005883,
KBio3_001029,
KBio3_001030,
KBio3_001821,
NSC2629,
NINDS_001018,
BCPP000246,
Bio1_000438,
Bio1_000927,
Bio1_001416,
Bio2_000448,
Bio2_000928,
HMS1362M17,
HMS1792M17,
HMS1990M17,
HMS2234M19,
HMS3266F04,
HMS3403M17,
HMS3654L15,
HMS3675L05,
Pharmakon1600-01503635,
ACT07289,
BCP26336,
HY-B0099,
KS-00000X6I,
NSC26139,
Tox21_112077,
Tox21_201747,
Tox21_302819,
BBL011741,
BDBM50200541,
CCG-39352,
NSC758622,
s1326,
STK201315,
ZINC18203737,
3-methyl-1-phenyl-2-pyrazolin-5one,
AKOS000313817,
Tox21_112077_1,
AC-4745,
BCP9000635,
CS-1832,
DB12243,
LS-1892,
MCI-186, Radicut, 89-25-8,
NE10266,
NSC-758622,
RL05601,
RTR-028045,
SB19128,
IDI1_001018,
IDI1_002203,
1-PEHNYL-3-METHYL-5-PYRAZALONE,
NCGC00018218-01,
NCGC00018218-02,
NCGC00018218-03,
NCGC00018218-04,
NCGC00018218-05,
NCGC00018218-06,
NCGC00018218-07,
NCGC00018218-08,
NCGC00018218-10,
NCGC00018218-17,
NCGC00022665-02,
NCGC00022665-04,
NCGC00022665-05,
NCGC00022665-06,
NCGC00256515-01,
NCGC00259296-01,
4CA-0486,
AJ-70469,
AK128848,
AN-11638,
BC205186,
SC-13582,
ST012744,
SBI-0051836.P002,
AB2000046,
DB-002517,
ST2410773,
TR-028045,
AM20060748,
FT-0608243,
SW148216-2,
5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone,
5-methyl-2-phenyl-2,4-dihydropyrazol-3-one,
3-Methyl-1-phenyl-2-pyrazoline-5-one, 99%,
4E-901,
5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one,
C13008,
D01552,
AB00375776_14,
AB00375776_15,
2 4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one,
2,4-dihydro-2-phenyl-5-methyl-3H-pyrazol-3-one,
I01-2810,
Q-200386,
SR-01000000135-2,
SR-01000000135-3,
SR-01000000135-5,
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one #,
BRD-K35458079-001-04-2,
BRD-K35458079-001-12-5,
BRD-K35458079-001-23-2,
Z50145861,
F0391-0021,
3-Methyl-1-phenyl-2-pyrazoline-5-one, SAJ special grade,
3-Methyl-1-phenyl-2-pyrazoline-5-one, purum, >=98.0% (NT),
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone),
Phenazone impurity A, European Pharmacopoeia (EP) Reference Standard,
Antipyrine Related Compound A, United States Pharmacopeia (USP) Reference Standard,
InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H,
edarabone,
3-Methyl-1-phenyl-5-pyrazolone,
Edaravone [INN],
3-Methoxybenzyl bromide,
Edaravone (JAN/INN),
UNII-S798V6YJRP,
D06DLI,
NSC-12,
NSC12,
S798V6YJRP,
C10H10N2O,
MCI 186,
MCI186,
3-methyl-1-phenyl-5-pyrazolon,
1 Phenyl 3 methyl 5 pyrazolone,
CID4021,
3-Methyl-1-phenylpyrazolin-5-one,
AR-1I7113,
C10-H10-N2-O,
3-Methyl-1-phenylpyrazol-5(4H)-one,
1-Phenyl-3-methyl-2-pyrazolin-5-one,
3 Methyl 1 phenyl 2 pyrazolin 5 one,
ACN-031831,
3- methyl- 1- phenyl- 5- pyrazolone,
5-METHYL-2-PHENYL-1,2-DIHYDROPYRAZOL-3-ONE,
Methyl-1-phenyl-2-pyrazolin-5-one, 3-,
A5059,
3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one,
A11725,
C005435,
3h-pirazol-3-ona, 2,4-dihidro-5-metil-2-fenil-,
D000077553,
PMP,
19735-89-8,
3-Methyl-1-phenyl-2-pyrazolin-5-one, 98%, a strong novel free radical scavenger - 100G 100g,
94849-87-3,
|
| Complexity | 241 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 174.079g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 13 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 174.203g/mol |
| Monoisotopic Mass | 174.079g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 32.7A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H303-H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P301+P312+P330-P305+P351+P338-P261 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

